Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Antidepressant effects of nicotine in an animal model of depression.

Tizabi Y, Overstreet DH, Rezvani AH, Louis VA, Clark E Jr, Janowsky DS, Kling MA.

Psychopharmacology (Berl). 1999 Feb;142(2):193-9.

PMID:
10102772
2.

Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression.

Overstreet DH, Pucilowski O, Rezvani AH, Janowsky DS.

Psychopharmacology (Berl). 1995 Sep;121(1):27-37. Review.

PMID:
8539339
3.
4.

The Flinders sensitive line rats: a genetic animal model of depression.

Overstreet DH.

Neurosci Biobehav Rev. 1993 Spring;17(1):51-68. Review.

PMID:
8455816
5.

The Flinders Sensitive Line rat: a selectively bred putative animal model of depression.

Overstreet DH, Friedman E, Mathé AA, Yadid G.

Neurosci Biobehav Rev. 2005;29(4-5):739-59. Epub 2005 Apr 22. Review.

PMID:
15925699
6.

Neuronal nicotinic receptor and psychiatric disorders: functional and behavioral effects of nicotine.

Araki H, Suemaru K, Gomita Y.

Jpn J Pharmacol. 2002 Feb;88(2):133-8. Review.

7.

Potential animal model of multiple chemical sensitivity with cholinergic supersensitivity.

Overstreet DH, Miller CS, Janowsky DS, Russell RW.

Toxicology. 1996 Jul 17;111(1-3):119-34. Review.

PMID:
8711728
8.

[Nicotine as an antidepressant and regulator of sleep in subjects with depression].

Vieyra-Reyes P, Venebra-Muñoz A, Rivas-Santiago B, García-García F.

Rev Neurol. 2009 Dec 16-31;49(12):661-7. Review. Spanish.

9.

Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.

Newhouse PA, Potter A, Levin ED.

Drugs Aging. 1997 Sep;11(3):206-28. Review.

PMID:
9303280
10.

Genetic and pharmacological models of cholinergic supersensitivity and affective disorders.

Overstreet DH, Russell RW, Crocker AD, Gillin JC, Janowsky DS.

Experientia. 1988 Jun 15;44(6):465-72. Review.

PMID:
3288493
11.

Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors.

Yu LF, Zhang HK, Caldarone BJ, Eaton JB, Lukas RJ, Kozikowski AP.

J Med Chem. 2014 Oct 23;57(20):8204-23. doi: 10.1021/jm401937a. Epub 2014 Jul 2. Review.

12.

Interactions of nicotine and drugs used in the treatment of mental illnesses with respect to cognitive functions.

Burda K, Czubak A, Nowakowska E, Kus K, Metelska J, Nowakowska A.

Arzneimittelforschung. 2010;60(9):527-43. doi: 10.1055/s-0031-1296322. Review.

PMID:
21117496
13.

The nicotinic acetylcholine receptor as a target for antidepressant drug development.

Philip NS, Carpenter LL, Tyrka AR, Price LH.

ScientificWorldJournal. 2012;2012:104105. doi: 10.1100/2012/104105. Epub 2012 Apr 24. Review.

14.

Modeling depression in animal models.

Overstreet DH.

Methods Mol Biol. 2012;829:125-44. doi: 10.1007/978-1-61779-458-2_7. Review.

PMID:
22231810
15.

Smoking and pain: pathophysiology and clinical implications.

Shi Y, Weingarten TN, Mantilla CB, Hooten WM, Warner DO.

Anesthesiology. 2010 Oct;113(4):977-92. doi: 10.1097/ALN.0b013e3181ebdaf9. Review.

PMID:
20864835
16.

The flinders sensitive line rat model of depression--25 years and still producing.

Overstreet DH, Wegener G.

Pharmacol Rev. 2013 Jan 10;65(1):143-55. doi: 10.1124/pr.111.005397. Print 2013 Jan. Review.

17.
18.

[Studies on animal model of depression: review and perspective].

Nomura S, Yamaoka K, Naitoh H.

Yakubutsu Seishin Kodo. 1989 Dec;9(4):349-58. Review. Japanese.

PMID:
2698019
19.

Differential effects of nicotine in inbred and selectively bred rodents.

Overstreet DH.

Behav Genet. 1995 Mar;25(2):179-85. Review.

PMID:
7733858
20.

Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics.

Zurkovsky L, Taylor WD, Newhouse PA.

Biochem Pharmacol. 2013 Oct 15;86(8):1133-44. doi: 10.1016/j.bcp.2013.07.032. Epub 2013 Aug 8. Review.

Supplemental Content

Support Center